The review consists of eight sections; Section 2, Section 3, Section 4, Section 5, Section 6 and Section 7 which brief the role of BTK in BCR signaling, its association with different malignancies and autoimmune diseases, and the approval status and chemistry of covalent and non-covalent inhibitors. Here, BTK is linked to autoimmune disease.